Thomas Strack
Chief Tech/Sci/R&D Officer chez VTV THERAPEUTICS INC.
Profil
Thomas Strack is currently the Chief Medical Officer at vTv Therapeutics, Inc. He previously worked as the Vice President of Clinical Affairs at Progenics Pharmaceuticals, Inc., Head of Metabolic Clinical Development at Takeda Global Research & Development Center, Inc., Head of Research & Development at Asubio Pharmaceutical, Inc., and Chief Medical Officer at Faeth Therapeutics, Inc. He holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Postes actifs de Thomas Strack
| Sociétés | Poste | Début |
|---|---|---|
| VTV THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 02/11/2023 |
Anciens postes connus de Thomas Strack
| Sociétés | Poste | Fin |
|---|---|---|
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - |
| Takeda Global Research & Development Center, Inc. | Corporate Officer/Principal | - |
Asubio Pharmaceutical, Inc.
 Asubio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Asubio Pharmaceutical, Inc. was into pharmaceuticals sector. The company was headquartered in Paramus, NY. | Chief Tech/Sci/R&D Officer | - |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Thomas Strack
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VTV THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Takeda Global Research & Development Center, Inc. | |
Asubio Pharmaceutical, Inc.
Asubio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Asubio Pharmaceutical, Inc. was into pharmaceuticals sector. The company was headquartered in Paramus, NY. | Health Technology |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Health Technology |
